IDH1 and neoplasm: Furthermore, we observed a correlation between elevated MRM score and malignancy features characterized by older age, mortality, absence of IDH1 mutation, higher tumor grading, lack of 1p19q co-deletion, and MGMT promoter methylation (Fig. 7).